Kunutsor Setor K, Khan Hassan, Laukkanen Jari A
School of Clinical Sciences, Southmead Hospital, University of Bristol, UK
Emory University School of Medicine, Atlanta, GA.
J Am Heart Assoc. 2016 Feb 8;5(2):e002858. doi: 10.1161/JAHA.115.002858.
γ-Glutamyltransferase (GGT) has been linked to an increased risk of several cardiovascular outcomes; however, the relationship of GGT with sudden cardiac death (SCD) has not been investigated previously. We aimed to assess the association of GGT with risk of SCD.
Serum GGT activity was assessed at baseline in the Kuopio Ischemic Heart Disease prospective cohort of 1780 men, and 136 SCDs were recorded during 22 years of follow-up. Correction for within-person variability was made using data from repeated measurements taken several years apart. The regression dilution ratio of loge GGT adjusted for age was 0.68 (95% CI 0.61-0.74). Serum GGT was log-linearly associated with risk of SCD. The hazard ratio for SCD per 1 SD higher baseline loge GGT values (2-fold higher) was 1.30 (95% CI 1.10-1.54; P=0.002) after adjustment for several established risk factors and remained consistent with further adjustment for alcohol consumption, resting heart rate, lipids, and C-reactive protein (hazard ratio 1.26, 95% CI 1.05-1.50; P=0.014). The corresponding hazard ratios were 1.48 (95% CI 1.15-1.89; P=0.002) and 1.40 (95% CI 1.07-1.82; P=0.014) after correction for within-person variability. Hazard ratios remained unchanged after accounting for incident coronary events and did not vary importantly by levels or categories of prespecified conventional risk factors.
GGT is positively, log-linearly, and independently associated with future risk of SCD in the general male population. Further research is needed to replicate these findings.
γ-谷氨酰转移酶(GGT)与多种心血管疾病结局风险增加有关;然而,GGT与心源性猝死(SCD)的关系此前尚未得到研究。我们旨在评估GGT与SCD风险之间的关联。
在库奥皮奥缺血性心脏病前瞻性队列研究中,对1780名男性进行了基线血清GGT活性评估,在22年的随访期间记录到136例SCD。利用相隔数年的重复测量数据对个体内变异性进行校正。校正年龄后的loge GGT回归稀释率为0.68(95%CI 0.61 - 0.74)。血清GGT与SCD风险呈对数线性相关。在调整了多个既定风险因素后,基线loge GGT值每升高1个标准差(升高2倍),SCD的风险比为1.30(95%CI 1.10 - 1.54;P = 0.002),在进一步调整饮酒量、静息心率、血脂和C反应蛋白后仍保持一致(风险比1.26,95%CI 1.05 - 1.50;P = 0.014)。校正个体内变异性后,相应的风险比分别为1.48(95%CI 1.15 - 1.89;P = 0.002)和1.40(95%CI 1.07 - 1.82;P = 0.014)。在考虑了新发冠心病事件后,风险比保持不变,且在预先设定的传统风险因素的水平或类别上没有显著差异。
在一般男性人群中,GGT与未来SCD风险呈正相关、对数线性相关且独立相关。需要进一步研究来重复这些发现。